Bright Minds Biosciences (DRUG) Competitors $39.61 -3.34 (-7.78%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DRUG vs. AVXL, IMNM, IGMS, CRON, ANNX, TRDA, TRML, STOK, ORIC, and PHVSShould you be buying Bright Minds Biosciences stock or one of its competitors? The main competitors of Bright Minds Biosciences include Anavex Life Sciences (AVXL), Immunome (IMNM), IGM Biosciences (IGMS), Cronos Group (CRON), Annexon (ANNX), Entrada Therapeutics (TRDA), Tourmaline Bio (TRML), Stoke Therapeutics (STOK), ORIC Pharmaceuticals (ORIC), and Pharvaris (PHVS). These companies are all part of the "pharmaceutical products" industry. Bright Minds Biosciences vs. Anavex Life Sciences Immunome IGM Biosciences Cronos Group Annexon Entrada Therapeutics Tourmaline Bio Stoke Therapeutics ORIC Pharmaceuticals Pharvaris Anavex Life Sciences (NASDAQ:AVXL) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk. Is AVXL or DRUG more profitable? Anavex Life Sciences' return on equity of -30.64% beat Bright Minds Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Anavex Life SciencesN/A -30.64% -28.23% Bright Minds Biosciences N/A -58.55%-53.79% Does the MarketBeat Community favor AVXL or DRUG? Anavex Life Sciences received 429 more outperform votes than Bright Minds Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformAnavex Life SciencesOutperform Votes42974.35% Underperform Votes14825.65% Bright Minds BiosciencesN/AN/A Which has more volatility & risk, AVXL or DRUG? Anavex Life Sciences has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Bright Minds Biosciences has a beta of -6.62, suggesting that its share price is 762% less volatile than the S&P 500. Do insiders and institutionals have more ownership in AVXL or DRUG? 31.6% of Anavex Life Sciences shares are owned by institutional investors. Comparatively, 40.5% of Bright Minds Biosciences shares are owned by institutional investors. 11.0% of Anavex Life Sciences shares are owned by company insiders. Comparatively, 42.7% of Bright Minds Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts prefer AVXL or DRUG? Anavex Life Sciences presently has a consensus price target of $40.00, suggesting a potential upside of 437.27%. Given Anavex Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Anavex Life Sciences is more favorable than Bright Minds Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, AVXL or DRUG? Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Anavex Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnavex Life SciencesN/AN/A-$47.51M-$0.50-14.89Bright Minds BiosciencesN/AN/A-$5.47M-$0.68-58.25 Does the media refer more to AVXL or DRUG? In the previous week, Anavex Life Sciences and Anavex Life Sciences both had 2 articles in the media. Bright Minds Biosciences' average media sentiment score of 1.45 beat Anavex Life Sciences' score of 0.47 indicating that Bright Minds Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Anavex Life Sciences Neutral Bright Minds Biosciences Positive SummaryAnavex Life Sciences beats Bright Minds Biosciences on 10 of the 14 factors compared between the two stocks. Ad Investors AlleyStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!Click here to see this breakthrough before everyone else → Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRUG vs. The Competition Export to ExcelMetricBright Minds BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$175.63M$6.39B$5.06B$8.66BDividend YieldN/A8.04%5.09%4.06%P/E Ratio-58.2510.80101.8517.37Price / SalesN/A245.131,196.8169.07Price / CashN/A53.4940.9136.36Price / Book30.479.306.335.87Net Income-$5.47M$154.14M$119.64M$225.66M7 Day Performance-15.04%-9.49%-5.12%-1.34%1 Month Performance37.53%-7.23%-3.21%1.00%1 Year Performance2,994.53%30.70%32.52%25.27% Bright Minds Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRUGBright Minds Biosciences2.3947 of 5 stars$39.61-7.8%N/A+2,994.5%$175.63MN/A-58.25N/AShort Interest ↓Positive NewsGap DownAVXLAnavex Life Sciences3.6309 of 5 stars$9.24+20.9%N/A+23.9%$783.55MN/A-18.4840High Trading VolumeIMNMImmunome1.4356 of 5 stars$12.98+3.5%N/A+24.9%$779.45M$14.02M-1.6940Analyst ForecastAnalyst RevisionNews CoverageIGMSIGM Biosciences4.6905 of 5 stars$13.03-9.3%N/A+64.4%$772.94M$2.13M-3.58190Earnings ReportShort Interest ↓CRONCronos Group1.8775 of 5 stars$2.00-2.9%N/A+7.5%$764.60M$87.24M-13.33356Short Interest ↓Analyst RevisionNews CoverageANNXAnnexon2.7007 of 5 stars$7.23-1.8%N/A+139.1%$763.88MN/A-5.8860Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageTRDAEntrada Therapeutics2.3061 of 5 stars$19.82+3.1%N/A+16.1%$741.66M$129.01M12.47110Insider SellingHigh Trading VolumeTRMLTourmaline Bio1.9857 of 5 stars$28.76+4.0%N/A+53.9%$737.41MN/A-10.2044Analyst RevisionNews CoverageSTOKStoke Therapeutics3.9035 of 5 stars$13.88+4.6%N/A+188.5%$735.22M$8.78M-6.61100News CoverageORICORIC Pharmaceuticals4.1718 of 5 stars$10.26+3.1%N/A+29.8%$723.76MN/A-5.8680Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpPHVSPharvaris1.8415 of 5 stars$22.61+1.3%N/A+30.4%$719.90MN/A-8.7630News Coverage Related Companies and Tools Related Companies Anavex Life Sciences Competitors Immunome Competitors IGM Biosciences Competitors Cronos Group Competitors Annexon Competitors Entrada Therapeutics Competitors Tourmaline Bio Competitors Stoke Therapeutics Competitors ORIC Pharmaceuticals Competitors Pharvaris Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DRUG) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
